YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Trasylol
FDA strengthens safety warning on aprotinin label
Dec 18, 2006 | www.theheart.org
The FDA has strengthened the label safety warning for the antifibrinolytic drug aprotinin (Trasylol, Bayer), emphasizing the importance of limiting...
FDA Approves New Warning for Bayer Drug
Dec 15, 2006 | AP
Government health officials said Friday they have approved a new label for Bayer's Trasylol that highlights the possible risk of kidney damage...
Bayer Suspends 2 Over Trasylol Data
Oct 13, 2006 | AP
Bayer AG said Friday it suspended two employees involved in the decision to withhold data from federal health officials showing the company's drug...
FDA Statement Regarding New Trasylol Data
Sep 29, 2006 | www.fda.gov
Since January, 2006, the Food and Drug Administration (FDA) has been conducting a safety review of Trasylol (aprotinin injection). The review was...
FDA Urges Limited Use of Trasylol Pending Review of Data Showing Increased Risks of Heart Attack, Stroke, and Kidney Failure
Feb 9, 2006 | Newsinferno News Staff
The Food and Drug Administration (FDA) has issued an advisory to doctors urging them to limit the use of Bayer AG’s heart-surgery medication,...
FDA Issues Public Health Advisory for Trasylol
Feb 8, 2006 | www.fda.gov
The Food and Drug Administration today issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that...
FDA Public Health Advisory Aprotinin Injection (marketed as Trasylol)
Feb 8, 2006 | www.fda.gov
On January 26, 2006, The New England Journal of Medicine (NEJM) published an article by Mangano et al. reporting an association of Trasylol...
Parker & Waichman, LLP Evaluating Trasylol Claims After Study Links Medication to Kidney Failure, Stroke and Heart Attack -- BAY
Jan 31, 2006 | PrimeZone
Parker & Waichman, LLP (www.yourlawyer.com) announces that, in addition to numerous inquiries from potential clients, it has been retained in a...
Heart-surgery drug risky, researchers find
Jan 26, 2006 | Los Angeles Times
A drug widely used during heart surgery to control bleeding doubles the risk of kidney damage, forcing an estimated 10,000 patients onto dialysis...
Study: Cardiac Drug Doubles Risk of Kidney Failure
Jan 26, 2006 | www.consumeraffairs.com
Aprotinin. a drug approved by the FDA, marketed internationally for the last 13 years, and given to an estimated one million surgery patients to...
Trasylol
